Bristol-Myers Squibb Co. (BMY) PT Lowered to $47 at BMO Capital
Tweet Send to a Friend
(Updated - August 1, 2025 8:27 AM EDT)
BMO Capital analyst Evan David Seigerman lowered the price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BMO Capital analyst Evan David Seigerman lowered the price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
